Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

161.

First-line treatment of indolent lymphoma: axing CHOP?

Lancet.
Jacobson CA, Freedman AS.
| Apr 6, 2013
162.

Evolution and impact of subclonal mutations in chronic lymphocytic leukemia.

Cell.
Landau DA, Carter SL, Stojanov P, McKenna A, Stevenson K, Lawrence MS, Sougnez C, Stewart C, Sivachenko A, Wang L, Wan Y, Zhang W, Shukla SA, Vartanov A, Fernandes SM, Saksena G, Cibulskis K, Tesar B, Gabriel S, Hacohen N, Meyerson M, Lander ES, Neuberg D, Brown JR, Getz G, Wu CJ.
| Feb 14, 2013
163.

Direct activation of full-length proapoptotic BAK.

Proc. Natl. Acad. Sci. U.S.A.
Leshchiner ES, Braun CR, Bird GH, Walensky LD.
| Mar 12, 2013
164.

(R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible.

Science.
Losman JA, Looper RE, Koivunen P, Lee S, Schneider RK, McMahon C, Cowley GS, Root DE, Ebert BL, Kaelin WG.
| Mar 29, 2013
165.

Service: an essential component of graduate medical education.

N. Engl. J. Med.
Kesselheim JC, Cassel CK.
| Feb 7, 2013
166.

Integrative eQTL-based analyses reveal the biology of breast cancer risk loci.

Cell.
Li Q, Seo JH, Stranger B, McKenna A, Pe'er I, Laframboise T, Brown M, Tyekucheva S, Freedman ML.
| Jan 31, 2013
167.

Cancer. Cancer cell phenotypes, in fifty shades of grey.

Science.
Marusyk A, Polyak K.
| Feb 1, 2013
168.

Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations.

Nat. Genet.
Brastianos PK, Horowitz PM, Santagata S, Jones RT, McKenna A, Getz G, Ligon KL, Palescandolo E, Van Hummelen P, Ducar MD, Raza A, Sunkavalli A, Macconaill LE, Stemmer-Rachamimov AO, Louis DN, Hahn WC, Dunn IF, Beroukhim R.
| 01 20, 2013
169.

Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors.

Nat. Genet.
Chmielecki J, Crago AM, Rosenberg M, O'Connor R, Walker SR, Ambrogio L, Auclair D, McKenna A, Heinrich MC, Frank DA, Meyerson M.
| 01 13, 2013
170.

Crystal structure of the HLA-DM-HLA-DR1 complex defines mechanisms for rapid peptide selection.

Cell.
Pos W, Sethi DK, Call MJ, Schulze MS, Anders AK, Pyrdol J, Wucherpfennig KW.
| Dec 21, 2012
171.

β-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis.

Cell.
Rosenbluh J, Nijhawan D, Cox AG, Li X, Neal JT, Schafer EJ, Zack TI, Wang X, Tsherniak A, Schinzel AC, Shao DD, Schumacher SE, Weir BA, Vazquez F, Cowley GS, Root DE, Mesirov JP, Beroukhim R, Kuo CJ, Goessling W, Hahn WC.
| Dec 21, 2012
172.

EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent.

Science.
Xu K, Wu ZJ, Groner AC, He HH, Cai C, Lis RT, Wu X, Stack EC, Loda M, Liu T, Xu H, Cato L, Thornton JE, Gregory RI, Morrissey C, Vessella RL, Montironi R, Magi-Galluzzi C, Kantoff PW, Balk SP, Liu XS, Brown M.
| Dec 14, 2012
173.

Signaling axis involving Hedgehog, Notch, and Scl promotes the embryonic endothelial-to-hematopoietic transition.

Proc. Natl. Acad. Sci. U.S.A.
Kim PG, Albacker CE, Lu YF, Jang IH, Lim Y, Heffner GC, Arora N, Bowman TV, Lin MI, Lensch MW, De Los Angeles A, Zon LI, Loewer S, Daley GQ.
| Jan 8, 2013
174.

A PGC-1α isoform induced by resistance training regulates skeletal muscle hypertrophy.

Cell.
Ruas JL, White JP, Rao RR, Kleiner S, Brannan KT, Harrison BC, Greene NP, Wu J, Estall JL, Irving BA, Lanza IR, Rasbach KA, Okutsu M, Nair KS, Yan Z, Leinwand LA, Spiegelman BM.
| Dec 7, 2012
175.

Cellular alchemy and the golden age of reprogramming.

Cell.
Daley GQ.
| Dec 7, 2012
176.

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial.

Lancet.
Demetri GD, Reichardt P, Kang YK, Blay JY, Rutkowski P, Gelderblom H, Hohenberger P, Leahy M, von Mehren M, Joensuu H, Badalamenti G, Blackstein M, Le Cesne A, Schöffski P, Maki RG, Bauer S, Nguyen BB, Xu J, Nishida T, Chung J, Kappeler C, Kuss I, Laurent D, Casali PG, Samonigg H.
| Jan 26, 2013
177.

Influence of threonine metabolism on S-adenosylmethionine and histone methylation.

Science.
Shyh-Chang N, Locasale JW, Lyssiotis CA, Zheng Y, Teo RY, Ratanasirintrawoot S, Zhang J, Onder T, Unternaehrer JJ, Zhu H, Asara JM, Daley GQ, Cantley LC.
| Jan 11, 2013
178.

Patients' expectations about effects of chemotherapy for advanced cancer.

N. Engl. J. Med.
Weeks JC, Catalano PJ, Cronin A, Finkelman MD, Mack JW, Keating NL, Schrag D.
| Oct 25, 2012
179.

Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival.

N. Engl. J. Med.
Liao X, Lochhead P, Nishihara R, Morikawa T, Kuchiba A, Yamauchi M, Imamura Y, Qian ZR, Baba Y, Shima K, Sun R, Nosho K, Meyerhardt JA, Giovannucci E, Fuchs CS, Chan AT, Ogino S.
| Oct 25, 2012
180.

Estrogen receptor prevents p53-dependent apoptosis in breast cancer.

Proc. Natl. Acad. Sci. U.S.A.
Bailey ST, Shin H, Westerling T, Liu XS, Brown M.
| Oct 30, 2012